2m 2m 2m 2m 2m 2m 2m
JAGUAR HEALTH (JAGX)
NASDAQ
$0.31-$0.001 (-0.32%)
Price as of Sep 11, 2026 7:52 PM EDT- $1.6MMarket Cap
- -99.50%1-Year Change
- BiotechnologyIndustry
JAGUAR HEALTH (JAGX)
$0.31-$0.001 (-0.32%)
JAGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.31 | ||
Change | -$0.005 (-1.57%) | ||
Open | $0.33 | ||
High | $0.33 | ||
Low | $0.29 | ||
Previous Close | $0.32 | ||
Volume | 410,815 | ||
30-Day Average Volume | 410,215 | ||
1-Week Change | -47.39% | ||
1-Month Change | -59.92% | ||
1-Year Change | -99.50% | ||
3-Year Change | -100.00% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 5.2M | ||
Total Assets | $34.2M | ||
Market Cap | $1.6M | ||
Enterprise Value | $13.4M | ||
Period: QTR TTM FY | |||
Revenue | $43,000.00 | ||
Net Income | -$12.8M | ||
Free Cash Flow | -$5.3M | ||
EBIT | -$12.6M | ||
EBITDA | -$12.2M | ||
Net Working Capital | -$7.8M | ||
EPS | -$15.70 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 311 | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 04/30/2026 | ||
Earnings & Revenue